The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market.
Facing issue in account approval? email us at info@ipt.pw
Click to Ckeck Our - FREE SEO TOOLS
The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market.
Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide. In the past decade, we have become a leader in discovering and manufacturing recombinant antibodies.
Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide. In the past decade, we have become a leader in discovering and manufacturing recombinant antibodies.
Creative Biolabs has established a powerful AntInfect™ Platform for anti-infectives biomolecular discovery. Our scientists have accumulated over a decade of experience in antibody and antimicrobial peptide (AMP) discovery for viral diseases. We are more than happy to share our experience and help our customers in anti-virus biomolecular development.
Creative Biolabs has accumulated extensive experience in Anti-Virus Biomolecular Discovery. Based on advanced platforms, our seasoned scientists are pleased to introduce the influenza virus broadly neutralizing antibodies (bNAbs) discovery service and antimicrobial peptides (AMPs) discovery service to all global customers.
Based on years of experience in antibody discovery and manufacture, Creative Biolabs has established a second to none bispecific antibodies (BsAbs) generation platform. With our comprehensive platform, we are proud to offer knobs-in-holes (KIH) BsAb generation service in a timely and cost-effective manner.
Orthogonal Fab Bispecific monoclonal Antibody
Rabbit RLA Genotyping
Rat RT1 Typing
SLC39A13 Membrane Protein
SLC39A3 Membrane Protein
Creative Biolabs is a leading global biologics company established in the United States. With more than a decade of exploration and expansion, Creative Biolabs offers comprehensive one-stop services for Complement Therapeutics. Our project procedure can be totally designed to meet your special requirements. We will be your best partner in Complement-based Drug Discovery.
Creative Biolabs is a leading global biologics company established in the United States. With more than a decade of exploration and expansion, Creative Biolabs offers comprehensive one-stop services for Complement Therapeutics. Our project procedure can be totally designed to meet your special requirements. We will be your best partner in Complement-based Drug Discovery.
Small molecule agonists as human pharmaceuticals
Small Molecule Antagonists
Creative Biolabs provides immune phage display antibody library screening services to generate highly specific antibodies that target common exosome markers and disease-specific markers. These antibodies can be used in the detection, identification, and phenotyping of exosomes, to aid in the study of their morphology and dynamics, and to help elucidate their physiological roles, etc.
The comparative quantitative analysis of complex protein samples can be through 2DE gel-based proteomics or mass spectrometry (MS)-based methods, using isobaric labeling reagents like isobaric tags for relative and absolute quantification (iTRAQ) and tandem mass tag (TMT) to achieve. At present, Creative Biolabs’ proteomics analysis platform has successfully realized the quantitative analysis of exosome samples.
In recent years, γδ T cells attract a lot of people's attention due to their efficient in vitro tumor killing activities. As a consequence, many researchers are currently studying the tumor killing function of γδ T cells in clinical trials. Although the reported benefits are modest, these studies have revealed that large γδ T-cell infusions were well tolerated. Many studies also demonstrated that γδ T cells not only can be used as effector cells, but also used as a novel cellular vaccine for the treatment of cancer patients. As a leading CRO company, Creative Biolabs provides a range of γδ T
γδ T cells are one type of innate immune cells, and their functions include cytotoxicity, cytokine secretion, antigen presentation, and crosstalk with other immune cells. In the process of infection, autoimmune reaction, or tumor development, γδ T cells are activated to stimulate, regulate, or even suppress the immune response. As a leader in the research of γδ T cells, Creative Biolabs is driven to provide comprehensive γδ T cells development and engineering services to promote their clinical application in HCV treatment.